Skip to main content

Table 4 Follow-up compliance

From: A day-to-day management model improves patient compliance to treatment for Helicobacter pylori infection: a prospective, randomized controlled study

 

Follow-up compliance rate

Timing of review UBT†

 

DTD group

OE group

P value

DTD group

OE group

P value

ITT

81.1% (103/127)

44.1% (56/127)

< 0.001

36.0 (31.0, 52.0)

73.0 (35.0, 242.0)

< 0.001

 95% CI

74.2–88.0%

35.3–52.8%

    

MITT

81.7% (103/126)

46.7% (56/120)

< 0.001

35.5 (31.0, 50.5)

64.5 (35.0, 219.0)

< 0.001

 95% CI

74.9–88.6%

37.6–55.7%

    

PP

87.3% (103/118)

70.0% (56/80)

0.003

35.0 (31.0, 43.3)

42.0 (32.0, 70.5)

0.001

 95% CI

81.2–93.4%

59.7–80.3%

    
  1. DTD, day-to-day; OE, outpatient education; UBT, urea breath test; ITT, intention-to-treat; MITT, modified intention-to-treat; PP, per-protocol; CI, confidence interval
  2. Values are shown as numbers (percentages) or median (interquartile range)
  3. †The timing of the review UBT is expressed as the number of days after the completion of the treatment
Back to article page

Gut Pathogens

ISSN: 1757-4749